Resveratrol (RSV), a polyphenol with anti-aging properties affecting metabolism and energy balance, is considered as a mimetic candidate to calorie restriction (CR). However its potential effects on delaying the onset of age-related diseases and increasing longevity have not yet been demonstrated in non-obese models close to humans such as non-human primates. The longitudinal monitoring of cognitive and motor performances, occurrence of age-related pathologies, age-related brain atrophy and mortality was performed from adulthood to death in a cohort of male grey mouse lemurs (Microcebus murinus, N = 33), all receiving 105 kJ/day of food but with a subset of 18 animals receiving RSV (200 mg.kg-1 body weight.day-1). RSV supplementation improved cognitive and motor performance at middle age as compared to control (CTL) animals. Median-lifespan was greater in RSV-fed animals (7.9 years compared to 6.4 years for CTL) but long-term RSV supplementation did not significantly affect all-cause nor age-related mortality. Also, brain grey matter atrophy accelerated in the RSV group at old age as compared to the CTL group. Altogether, these results suggest that long-term RSV supplementation procures health benefits at middle-age in male mouse lemurs but has limited long-term effects on health and longevity and might even impair brain integrity at older ages. Long-term resveratrol supplementation procures health benefits at middle-age in a non-human primate but does not mimic the positive effects of calorie restriction on lifespan and might even impair brain integrity at older ages.
No takes yet. Share an insight, caveat, or question.
Pifferi et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: